- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
DIM
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Sartorius Stedim Biotech S.A. · Healthcare · Medical Instruments & Supplies
Latest close
178.6 EUR
4.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is 1.9% above the Trend Line and sits at 38.2% of its 52-week range. The latest completed week returned 4.9%, after a -2.7% four-week move. The latest news-sentiment score is 50/100.
Setup score
30
out of 100
Latest Close
178.6 EUR
7 Aug 2026
1W Return
4.9%
latest completed week
4W Return
-2.7%
short-term follow-through
12W Return
12.1%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
-
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
Price follow-through
4.9%
Latest completed week; four-week move -2.7%.
Indicator stack
11/60
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.9% above the Trend Line and sits at 38.2% of its 52-week range. The latest completed week returned 4.9%, after a -2.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is - the 13-week average. Participation data is incomplete.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2712-week average 0.16
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -2.7% over four weeks, 12.1% over 12 weeks, and 7.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.56Latest activity-pressure read.
Pressure change3.6%Four-week change in activity pressure.
Leadership-21.13Latest relative-leadership reading.
RS change-11.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-19.4%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+9.2%Week of 17 Apr.
Worst week-14.7%Week of 24 Apr.
Latest week+4.9%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains6
Flat weeks0
Modest losses8
Sharp losses4
Recent vol5.3%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank77 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Instruments & Supplies
4-week rank14 / 18
Group average3.2%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD83.3%positive activity pressure
RS11.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.27; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Sartorius Stedim Biotech (ENXTPA:DIM) Stock Faces Rich P/E As Margins Improve To 9.7% Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 178.6 EUR | 4.9% | 175.3 EUR | 196.5 EUR | 0.56 | -21.13 | 0 | Off |
| 31 Jul 2026 | 170.3 EUR | 2.7% | 176.6 EUR | 197.0 EUR | 0.59 | -22.89 | 57 | Off |
| 24 Jul 2026 | 165.9 EUR | -11.0% | 177.9 EUR | 197.7 EUR | 0.66 | -25.36 | 578 | Off |
| 17 Jul 2026 | 186.4 EUR | 1.5% | 179.2 EUR | 198.4 EUR | 0.74 | -15.50 | 335 | Off |
| 10 Jul 2026 | 183.6 EUR | 2.3% | 179.8 EUR | 198.7 EUR | 0.54 | -18.93 | 0 | Off |
| 3 Jul 2026 | 179.5 EUR | 2.8% | 180.6 EUR | 198.9 EUR | 0.46 | -22.45 | 0 | Off |
| 26 Jun 2026 | 174.6 EUR | 6.9% | 181.7 EUR | 199.2 EUR | 0.43 | -23.47 | 0 | Off |
| 19 Jun 2026 | 163.4 EUR | -7.2% | 182.7 EUR | 199.4 EUR | 0.49 | -30.42 | 0 | Off |
| 12 Jun 2026 | 176.0 EUR | -2.1% | 183.5 EUR | 199.9 EUR | 0.51 | -22.73 | 0 | Off |
| 5 Jun 2026 | 179.7 EUR | -0.8% | 183.9 EUR | 200.5 EUR | 0.28 | -19.60 | 0 | Off |
| 29 May 2026 | 181.2 EUR | 5.6% | 184.2 EUR | 201.0 EUR | 0.07 | -20.35 | 6 | Off |
| 22 May 2026 | 171.6 EUR | 7.7% | 185.1 EUR | 201.4 EUR | -0.35 | -23.04 | 0 | Off |
| 15 May 2026 | 159.3 EUR | -3.5% | 186.4 EUR | 201.9 EUR | -0.63 | -27.60 | 0 | Off |
| 8 May 2026 | 165.0 EUR | 7.0% | 187.9 EUR | 202.4 EUR | -0.58 | -25.97 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.